205 related articles for article (PubMed ID: 28782677)
1. The value of ESWAN in diagnosis and differential diagnosis of prostate cancer: Preliminary study.
Xin JY; Gao SS; Liu JG; Sun CF; Han Y; Sun XH; Wang XZ; Wang B
Magn Reson Imaging; 2017 Dec; 44():26-31. PubMed ID: 28782677
[TBL] [Abstract][Full Text] [Related]
2. The enhanced T
Han X; Sun M; Wang M; Fan R; Chen D; Xie L; Liu A
Eur J Radiol; 2019 Sep; 118():187-193. PubMed ID: 31439240
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis of transition zone prostate cancer using T2-weighted (T2W) MRI: comparison of subjective features and quantitative shape analysis.
Krishna S; Schieda N; McInnes MD; Flood TA; Thornhill RE
Eur Radiol; 2019 Mar; 29(3):1133-1143. PubMed ID: 30105411
[TBL] [Abstract][Full Text] [Related]
4. Use of enhanced T2 star-weighted angiography (ESWAN) and R2* values to distinguish ovarian cysts due to endometriosis from other causes.
Li Y; Song QW; Sun MY; Wang HQ; Wang S; Wei Q; Liu JH; Tian SF; Tong ZB; Liu AL
Abdom Imaging; 2015 Aug; 40(6):1733-41. PubMed ID: 25504223
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer vs. post-biopsy hemorrhage: diagnosis with T2- and diffusion-weighted imaging.
Rosenkrantz AB; Kopec M; Kong X; Melamed J; Dakwar G; Babb JS; Taouli B
J Magn Reson Imaging; 2010 Jun; 31(6):1387-94. PubMed ID: 20512891
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of different mathematical models and different b-value ranges of diffusion-weighted imaging in peripheral zone prostate cancer detection using b-value up to 4500 s/mm2.
Feng Z; Min X; Margolis DJ; Duan C; Chen Y; Sah VK; Chaudhary N; Li B; Ke Z; Zhang P; Wang L
PLoS One; 2017; 12(2):e0172127. PubMed ID: 28199367
[TBL] [Abstract][Full Text] [Related]
7. Using Genetic and Epigenetic Markers to Improve Differential Diagnosis of Prostate Cancer and Benign Prostatic Hyperplasia by Noninvasive Methods in Mexican Patients.
Sánchez BE; Aguayo A; Martínez B; Rodríguez F; Marmolejo M; Svyryd Y; Luna L; Muñoz LA; Jiménez MA; Sotomayor M; Vargas V F; Mutchinick OM
Clin Genitourin Cancer; 2018 Aug; 16(4):e867-e877. PubMed ID: 29571584
[TBL] [Abstract][Full Text] [Related]
8. Diffusion-weighted imaging of prostate cancer using a statistical model based on the gamma distribution.
Shinmoto H; Oshio K; Tamura C; Soga S; Okamura T; Yamada K; Kaji T; Mulkern RV
J Magn Reson Imaging; 2015 Jul; 42(1):56-62. PubMed ID: 25223894
[TBL] [Abstract][Full Text] [Related]
9. Discrimination of men with prostate cancer from those with benign disease by measurements of human glandular kallikrein 2 (HK2) in serum.
Becker C; Piironen T; Pettersson K; Björk T; Wojno KJ; Oesterling JE; Lilja H
J Urol; 2000 Jan; 163(1):311-6. PubMed ID: 10604382
[TBL] [Abstract][Full Text] [Related]
10. Revisiting quantitative multi-parametric MRI of benign prostatic hyperplasia and its differentiation from transition zone cancer.
Chatterjee A; Gallan AJ; He D; Fan X; Mustafi D; Yousuf A; Antic T; Karczmar GS; Oto A
Abdom Radiol (NY); 2019 Jun; 44(6):2233-2243. PubMed ID: 30955071
[TBL] [Abstract][Full Text] [Related]
11. Oxidised low-density lipoprotein, a possible distinguishing lipid profile biomolecule between prostate cancer and benign prostatic hyperplasia.
Asare GA; Owusu-Boateng E; Asiedu B; Amoah BY; Essendoh E; Otoo RY
Andrologia; 2019 Sep; 51(8):e13321. PubMed ID: 31145504
[TBL] [Abstract][Full Text] [Related]
12. Biexponential apparent diffusion coefficients values in the prostate: comparison among normal tissue, prostate cancer, benign prostatic hyperplasia and prostatitis.
Liu X; Peng W; Zhou L; Wang H
Korean J Radiol; 2013; 14(2):222-32. PubMed ID: 23483254
[TBL] [Abstract][Full Text] [Related]
13. Assessment of brain maturation in the preterm infants using diffusion tensor imaging (DTI) and enhanced T2 star weighted angiography (ESWAN).
Ling X; Tang W; Liu G; Huang L; Li B; Li X; Liu S; Xu J
Eur J Radiol; 2013 Sep; 82(9):e476-83. PubMed ID: 23639775
[TBL] [Abstract][Full Text] [Related]
14. Differentiating prostate cancer from benign prostatic hyperplasia using whole-lesion histogram and texture analysis of diffusion- and T2-weighted imaging.
Xing P; Chen L; Yang Q; Song T; Ma C; Grimm R; Fu C; Wang T; Peng W; Lu J
Cancer Imaging; 2021 Sep; 21(1):54. PubMed ID: 34579789
[TBL] [Abstract][Full Text] [Related]
15. Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging.
Engelbrecht MR; Huisman HJ; Laheij RJ; Jager GJ; van Leenders GJ; Hulsbergen-Van De Kaa CA; de la Rosette JJ; Blickman JG; Barentsz JO
Radiology; 2003 Oct; 229(1):248-54. PubMed ID: 12944607
[TBL] [Abstract][Full Text] [Related]
16. Diffusion-tensor MRI at 3 T: differentiation of central gland prostate cancer from benign prostatic hyperplasia.
Park SY; Kim CK; Park BK; Ha SY; Kwon GY; Kim B
AJR Am J Roentgenol; 2014 Mar; 202(3):W254-62. PubMed ID: 24555622
[TBL] [Abstract][Full Text] [Related]
17. Computer-aided diagnosis of prostate cancer in the peripheral zone using multiparametric MRI.
Niaf E; Rouvière O; Mège-Lechevallier F; Bratan F; Lartizien C
Phys Med Biol; 2012 Jun; 57(12):3833-51. PubMed ID: 22640958
[TBL] [Abstract][Full Text] [Related]
18. Expression analysis of osteopontin mRNA splice variants in prostate cancer and benign prostatic hyperplasia.
Tilli TM; Thuler LC; Matos AR; Coutinho-Camillo CM; Soares FA; da Silva EA; Neves AF; Goulart LR; Gimba ER
Exp Mol Pathol; 2012 Feb; 92(1):13-9. PubMed ID: 21963599
[TBL] [Abstract][Full Text] [Related]
19. Identification of microRNAs differentially expressed in prostatic secretions of patients with prostate cancer.
Guzel E; Karatas OF; Semercioz A; Ekici S; Aykan S; Yentur S; Creighton CJ; Ittmann M; Ozen M
Int J Cancer; 2015 Feb; 136(4):875-9. PubMed ID: 24976077
[TBL] [Abstract][Full Text] [Related]
20. A valuable MRI examination method for prostate cancer screening.
Yang X; Shan L; Cao H; Jiang X; Ma X
Medicine (Baltimore); 2020 Nov; 99(48):e23134. PubMed ID: 33235074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
